- Home
- MLAB vs GHRS Comparison
MLAB vs GHRS Comparison
Compare MLAB & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- GHRS
- Stock Information
- Founded
- MLAB 1982
- GHRS 2018
- Country
- MLAB United States
- GHRS Ireland
- Employees
- MLAB N/A
- GHRS N/A
- Industry
- MLAB Industrial Machinery/Components
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- MLAB Industrials
- GHRS Health Care
- Exchange
- MLAB Nasdaq
- GHRS Nasdaq
- Market Cap
- MLAB 680.0M
- GHRS 583.1M
- IPO Year
- MLAB N/A
- GHRS 2021
- Fundamental
- Price
- MLAB $123.84
- GHRS $10.60
- Analyst Decision
- MLAB Hold
- GHRS Strong Buy
- Analyst Count
- MLAB 2
- GHRS 8
- Target Price
- MLAB $140.00
- GHRS $30.63
- AVG Volume (30 Days)
- MLAB 38.2K
- GHRS 148.1K
- Earning Date
- MLAB 05-30-2025
- GHRS 05-08-2025
- Dividend Yield
- MLAB 0.52%
- GHRS N/A
- EPS Growth
- MLAB N/A
- GHRS N/A
- EPS
- MLAB N/A
- GHRS N/A
- Revenue
- MLAB $237,747,000.00
- GHRS N/A
- Revenue This Year
- MLAB $13.48
- GHRS N/A
- Revenue Next Year
- MLAB $4.74
- GHRS N/A
- P/E Ratio
- MLAB N/A
- GHRS N/A
- Revenue Growth
- MLAB 11.68
- GHRS N/A
- 52 Week Low
- MLAB $83.68
- GHRS $6.00
- 52 Week High
- MLAB $155.12
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- MLAB 58.56
- GHRS 59.36
- Support Level
- MLAB $116.81
- GHRS $9.81
- Resistance Level
- MLAB $128.55
- GHRS $11.50
- Average True Range (ATR)
- MLAB 4.62
- GHRS 0.72
- MACD
- MLAB 1.56
- GHRS 0.23
- Stochastic Oscillator
- MLAB 76.09
- GHRS 89.60
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.